Search research articles
Contact Us
Filters
Showing results (31-40 of 172) with videos related to
Page
of 18
Sort By:
Circulation
|
November 1, 1994
Gastroepiploic and inferior epigastric arteries for coronary artery bypass. Early results and evolving applications
A E Manapat, P M McCarthy, B W Lytle, et al.
Circulation
|
December 22, 1999
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy
S P Marso, A M Lincoff, S G Ellis, et al.
Journal of the American College of Cardiology
|
October 3, 2003
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)
Albert W Chan, David J Moliterno, Peter B Berger, et al.
The American Journal of Cardiology
|
March 7, 2001
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy
J G Peterson, E J Topol, M T Roe, et al.
Circulation
|
December 6, 2001
Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial
M A Lauer, P L Houghtaling, J G Peterson, et al.
The New England Journal of Medicine
|
July 29, 1999
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators
A M Lincoff, R M Califf, D J Moliterno, et al.
The Annals of Thoracic Surgery
|
September 2, 2000
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing
A M Lincoff, L A LeNarz, G J Despotis, et al.
American Heart Journal
|
November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry
B M Scirica, D J Moliterno, N R Every, et al.
The American Journal of Cardiology
|
November 24, 1999
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators
B M Scirica, D J Moliterno, N R Every, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2007
A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection
Ying Huang, Huiying Yang, Brian B Borg, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 172) with videos related to
Sort By:
Page
of 18
Circulation
|
November 1, 1994
Gastroepiploic and inferior epigastric arteries for coronary artery bypass. Early results and evolving applications
A E Manapat, P M McCarthy, B W Lytle, et al.
Circulation
|
December 22, 1999
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy
S P Marso, A M Lincoff, S G Ellis, et al.
Journal of the American College of Cardiology
|
October 3, 2003
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)
Albert W Chan, David J Moliterno, Peter B Berger, et al.
The American Journal of Cardiology
|
March 7, 2001
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy
J G Peterson, E J Topol, M T Roe, et al.
Circulation
|
December 6, 2001
Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial
M A Lauer, P L Houghtaling, J G Peterson, et al.
The New England Journal of Medicine
|
July 29, 1999
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators
A M Lincoff, R M Califf, D J Moliterno, et al.
The Annals of Thoracic Surgery
|
September 2, 2000
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing
A M Lincoff, L A LeNarz, G J Despotis, et al.
American Heart Journal
|
November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry
B M Scirica, D J Moliterno, N R Every, et al.
The American Journal of Cardiology
|
November 24, 1999
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators
B M Scirica, D J Moliterno, N R Every, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2007
A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection
Ying Huang, Huiying Yang, Brian B Borg, et al.
Page
of 18